Covivio (COV) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Dec, 2025Executive summary
Achieved strong operational and financial performance in 2024, with recurring net income up 10% to €477.4 million and robust portfolio transformation across hotels, offices, and German residential segments.
Portfolio value stabilized in H2 2024 (+0.2%), with 97.2% occupancy and a 98.5% environmental certification rate.
Over €1.1 billion invested, mainly in hotels, and €766 million in disposals at a 3% premium to appraisal values.
Dividend proposal of €3.50 per share, up 6% year-over-year, reflecting robust cash flow and balance sheet strength.
Financial highlights
Group share revenues rose 5% at constant scope to €680 million, with total revenue growth of 6.7% in 2024, driven by hotels (+7.2%), offices (+8.1%), and German residential (+4.3%).
Adjusted EPRA earnings up 10% to €477.4 million, with EPS stable at €4.47 due to increased share count.
Net rental income grew 5% to €585.3 million; EBITDA from hotel operations up 34% to €43.3 million.
Operating income rebounded to €236.9 million from a loss in 2023, reflecting improved property values and disposals.
EPRA NTA per share at €79.8 at year-end, up 2.7% from H1 2024 but down 5% year-over-year.
Outlook and guidance
2025 recurring net result (Adjusted EPRA Earnings) guidance set at €495 million, up 4% year-over-year, with stable EPS expected.
Growth to be driven by full effect of hotel reinforcement, asset swaps, and dynamic rental growth, partially offset by higher financing costs and disposals.
Dividend proposed to increase by 6% to €3.50 per share, returning to full cash payout.
Latest events from Covivio
- Recurring net result per share up 6.4%, NAV per share up 3.9%, and 2026 targets 4% further growth.COV
H2 202520 Feb 2026 - Revenue up 4.8% with 2025 guidance confirmed; strong operations and ESG leadership.COV
Q3 202520 Feb 2026 - Recurring net result up 3.3%, guidance raised, and hotel exposure increased to 20%.COV
H1 20243 Feb 2026 - Recurring net result up 14% and 2025 guidance raised on strong H1 and market recovery.COV
H1 202527 Jan 2026 - Q1 2025 revenue up 5.4%, with high occupancy and guidance and dividend increase confirmed.COV
Q1 202527 Jan 2026 - Revenue up 6.8% like-for-like, occupancy at 97.3%, and €391m in disposals signed.COV
Q3 202419 Jan 2026 - Balanced growth, centrality, and ESG leadership drive portfolio transformation to 2030.COV
CMD 202412 Jan 2026